118 related articles for article (PubMed ID: 11063672)
1. Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling.
Liede A; Metcalfe K; Hanna D; Hoodfar E; Snyder C; Durham C; Lynch HT; Narod SA
Am J Hum Genet; 2000 Dec; 67(6):1494-504. PubMed ID: 11063672
[TBL] [Abstract][Full Text] [Related]
2. Potential excess mortality in BRCA1/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanoma.
Mai PL; Chatterjee N; Hartge P; Tucker M; Brody L; Struewing JP; Wacholder S
PLoS One; 2009; 4(3):e4812. PubMed ID: 19277124
[TBL] [Abstract][Full Text] [Related]
3. Incorporating information regarding preimplantation genetic diagnosis into discussions concerning testing and risk management for BRCA1/2 mutations: a qualitative study of patient preferences.
Hurley K; Rubin LR; Werner-Lin A; Sagi M; Kemel Y; Stern R; Phillips A; Cholst I; Kauff N; Offit K
Cancer; 2012 Dec; 118(24):6270-7. PubMed ID: 22736296
[TBL] [Abstract][Full Text] [Related]
4. Breast Cancer Risk Perceptions among Relatives of Women with Uninformative Negative BRCA1/2 Test Results: The Moderating Effect of the Amount of Shared Information.
Himes DO; Clayton MF; Donaldson GW; Ellington L; Buys SS; Kinney AY
J Genet Couns; 2016 Apr; 25(2):258-69. PubMed ID: 26245632
[TBL] [Abstract][Full Text] [Related]
5. Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations.
Finlay E; Stopfer JE; Burlingame E; Evans KG; Nathanson KL; Weber BL; Armstrong K; Rebbeck TR; Domchek SM
Genet Test; 2008 Mar; 12(1):81-91. PubMed ID: 18373407
[TBL] [Abstract][Full Text] [Related]
6. Physicians' experiences with BRCA1/2 testing in community settings.
Keating NL; Stoeckert KA; Regan MM; DiGianni L; Garber JE
J Clin Oncol; 2008 Dec; 26(35):5789-96. PubMed ID: 19001322
[TBL] [Abstract][Full Text] [Related]
7. Barriers and facilitators to BRCA genetic counseling among at-risk Latinas in New York City.
Sussner KM; Jandorf L; Thompson HS; Valdimarsdottir HB
Psychooncology; 2013 Jul; 22(7):1594-604. PubMed ID: 22987526
[TBL] [Abstract][Full Text] [Related]
8. Genetic counseling content: How does it impact health behavior?
Kelly KM; Ellington L; Schoenberg N; Jackson T; Dickinson S; Porter K; Leventhal H; Andrykowski M
J Behav Med; 2015 Oct; 38(5):766-76. PubMed ID: 25533642
[TBL] [Abstract][Full Text] [Related]
9. Patient outcomes associated with group and individual genetic counseling formats.
Rothwell E; Kohlmann W; Jasperson K; Gammon A; Wong B; Kinney A
Fam Cancer; 2012 Mar; 11(1):97-106. PubMed ID: 22057473
[TBL] [Abstract][Full Text] [Related]
10. Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer .
Kurian AW; Griffith KA; Hamilton AS; Ward KC; Morrow M; Katz SJ; Jagsi R
JAMA; 2017 Feb; 317(5):531-534. PubMed ID: 28170472
[No Abstract] [Full Text] [Related]
11. Genetic counselors: translating genomic science into clinical practice.
Bennett RL; Hampel HL; Mandell JB; Marks JH
J Clin Invest; 2003 Nov; 112(9):1274-9. PubMed ID: 14597750
[TBL] [Abstract][Full Text] [Related]
12. Comparing family members' motivations and attitudes towards genetic testing for hereditary breast and ovarian cancer: a qualitative analysis.
Dancyger C; Smith JA; Jacobs C; Wallace M; Michie S
Eur J Hum Genet; 2010 Dec; 18(12):1289-95. PubMed ID: 20648056
[TBL] [Abstract][Full Text] [Related]
13. Web-based return of BRCA2 research results: one-year genetic counselling experience in Iceland.
Stefansdottir V; Thorolfsdottir E; Hognason HB; Patch C; van El C; Hentze S; Cordier C; Mendes Á; Jonsson JJ
Eur J Hum Genet; 2020 Dec; 28(12):1656-1661. PubMed ID: 32523053
[TBL] [Abstract][Full Text] [Related]
14. Knowledge and perceptions of BRCA1/2 genetic testing and needs of diverse women with a personal or family history of breast cancer in South Florida.
Jones T; Howard H; Freeman-Costin K; Creighton A; Wisdom-Chambers K; Underhill-Blazey M
J Community Genet; 2021 Jul; 12(3):415-429. PubMed ID: 33555545
[TBL] [Abstract][Full Text] [Related]
15. Uptake of genetic testing among patients seeking cancer genetic counseling in Taiwan.
Fang SY; Hsieh LL; Hung CF; Wang YA
J Genet Couns; 2024 Apr; 33(2):322-328. PubMed ID: 37194127
[TBL] [Abstract][Full Text] [Related]
16. An Australian mainstream genetic testing program: Clinicians views about current and future practices.
Young AL; Ip E; Scheinberg T; Harrison M; Beale P; Goodwin A
Asia Pac J Clin Oncol; 2024 Feb; 20(1):119-127. PubMed ID: 37985938
[TBL] [Abstract][Full Text] [Related]
17. Educational needs about cancer family history and genetic counseling for cancer risk among frontline healthcare clinicians in New York City.
Sussner KM; Jandorf L; Valdimarsdottir HB
Genet Med; 2011 Sep; 13(9):785-93. PubMed ID: 21555944
[TBL] [Abstract][Full Text] [Related]
18. Perspectives of carriers of X-linked retinal diseases on genetic testing and gene therapy: A global survey.
Gocuk SA; Edwards TL; Jolly JK; Ayton LN
Clin Genet; 2024 Feb; 105(2):150-158. PubMed ID: 37859457
[TBL] [Abstract][Full Text] [Related]
19. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
Antoniou A; Pharoah PD; Narod S; Risch HA; Eyfjord JE; Hopper JL; Loman N; Olsson H; Johannsson O; Borg A; Pasini B; Radice P; Manoukian S; Eccles DM; Tang N; Olah E; Anton-Culver H; Warner E; Lubinski J; Gronwald J; Gorski B; Tulinius H; Thorlacius S; Eerola H; Nevanlinna H; Syrjäkoski K; Kallioniemi OP; Thompson D; Evans C; Peto J; Lalloo F; Evans DG; Easton DF
Am J Hum Genet; 2003 May; 72(5):1117-30. PubMed ID: 12677558
[TBL] [Abstract][Full Text] [Related]
20. Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature.
Liede A; Karlan BY; Narod SA
J Clin Oncol; 2004 Feb; 22(4):735-42. PubMed ID: 14966099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
